You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Adaptive camera to display mappings using computer vision

    SBC: POLAR RAIN, INC.            Topic: N/A

    The video surveillance industry is experiencing dramatic change with the move from analog to digital video. Command centers need to have coordinated viewing of multiple camera feeds at one time, and the ability to switch automatically between feeds and display relevant patterns. Conventional security control rooms include a bank of monitors connected through a switch to an array of security camera ...

    STTR Phase I 2006 Department of Homeland Security
  2. Family Empowerment: Adapting Successful Disclosure Strategies for HIV+ Parents

    SBC: SCIENCE2MARKET, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): One million adults in the US and 42 million families globally must decide if, to whom, when, and how to disclose their HIV+ serostatus. Often, disclosure of serostatus has a long-term negative impact on children and extended family members of HIV+ parents; this team has developed a coping-skills intervention that can positively impact the adjustment over 6 year ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  3. Micro-Targeting Capillary Ballistic Delivery System

    SBC: Seashell Technology LLC            Topic: N/A

    Methods for the delivery of therapeutics, tracking dyes, genes and other substances into complex neural tissue, organotypic cultures and cell types are limited in their effectiveness. The biolistic process, based upon acceleration of carrier particles to sufficient velocity, has recently been shown to be a relatively effectual delivery method for neuronal systems. However, cell damage and tissue d ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  4. Recombinant system for ultra-large scale biomanufacturing of therapeutic proteins

    SBC: SOLAZYME, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Solazyme, Inc. in collaboration with the City University of New York (CUNY) proposes to develop a novel recombinant protein expression platform by transforming the photosynthetic microalgal species Dunaliella salina. The organism's autotrophic production of nutrients from sunlight and extreme halotolerance will allow new biomanufacturing processes to overcome t ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  5. Device for Acamprosate Transcutaneous Delivery to Reduce Alcohol Consumption.

    SBC: Technova Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): Alcohol dependence is a chronic disorder with genetic, psychosocial, and environmental underpinnings. Alcohol's societal impact is widespread; it is estimated that there are 17.6 million individuals who abuse or depend on alcohol in the United States. (Grant et al, 2004). Alcohol dependence is considered the third leading preventable cause of death in the Unite ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  6. Live cell and HCS assays to quantify production of cardiomyocytes from stem cells

    SBC: VALA SCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Heart failure is a leading cause of mortality in modern society, and is results from the death of cardiac myocytes. Contractile function of failing hearts can be restored by injecting the heart with embryonic stem cell-derived cardiac myocytes (ESCMs) which integrate into the host tissue. To facilitate production of ESCMs, high throughput screening systems are ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  7. Development automated assay-regulators insulin synthesis

    SBC: VALA SCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): We propose to develop an automated screen for small molecules that modulate insulin promoter activity. The assay is based upon a mouse insulinoma, MIN6, that normally expresses insulin mRNA. This cell was engineered to stably contain two cassettes that use a fluorescent reporter protein to monitor insulin promoter activity and a housekeeping gene activity. The ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  8. Endoscopic Detection of Fluorescein for Sentinel Lymph Node Biopsy

    SBC: VESTAN INC            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this grant is to develop fluorescence endoscopy instrumentation to facilitate the surgical management of breast cancer, with possible application to other types of cancer. The specific aims for this project are to develop a combination holographic notch filter adapter and switchable high-intensity LED light source adapter for currently availabl ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  9. Novel Treatment for Degenerative Myopia

    SBC: VISDEX CORP            Topic: N/A

    DESCRIPTION (provided by applicant): Photopolymerization has provided a powerful tool for tissue engineering through localized synthesis of therapeutic materials in situ. To date, strategies to create photopolymerized networks on the surface of a tissue, such as the inner lumen of a blood vessel or on the fracture surface of a bone have received the most attention. The proposal will demonstrate a ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  10. Development of Nur77/TR3 Peptide Mimetics for the Treatment of Cancer

    SBC: VIVO LABORATORY, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Apoptosis is well recognized as an important biological process that controls cancer development and progression and the efficacy of chemotherapeutic drugs depends largely on their ability to induce apoptosis. Modern biology has suggested that cancer drug discovery based on molecular differences between tumor and normal cells is a feasible approach. Bcl-2, a cr ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government